616238-78-9 Usage
Description
Benzo[b]thiophene-2-carboxylic acid, 7-amino-, methyl ester (9CI) is a chemical compound with the molecular formula C11H11NO2S. It is a methyl ester of benzo[b]thiophene-2-carboxylic acid, containing an amino group at the 7th position. Benzo[b]thiophene-2-carboxylic acid, 7-amino-, methyl ester (9CI) has potential applications in organic synthesis and pharmaceutical research.
Uses
Used in Organic Synthesis:
Benzo[b]thiophene-2-carboxylic acid, 7-amino-, methyl ester (9CI) is used as a building block for the synthesis of various bioactive compounds. Its unique structure allows for the creation of a wide range of chemical entities with potential applications in various industries.
Used in Pharmaceutical Research:
Benzo[b]thiophene-2-carboxylic acid, 7-amino-, methyl ester (9CI) is used as a pharmaceutical intermediate. Its presence of an amino group at the 7th position makes it a promising candidate for the development of new drugs and therapeutic agents.
Used in Drug Development and Medicinal Chemistry Research:
Benzo[b]thiophene-2-carboxylic acid, 7-amino-, methyl ester (9CI) may have potential biological activities, making it a target for drug development and medicinal chemistry research. Further studies and research are needed to explore its full potential and applications in this field.
Check Digit Verification of cas no
The CAS Registry Mumber 616238-78-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,6,2,3 and 8 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 616238-78:
(8*6)+(7*1)+(6*6)+(5*2)+(4*3)+(3*8)+(2*7)+(1*8)=159
159 % 10 = 9
So 616238-78-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H9NO2S/c1-13-10(12)8-5-6-3-2-4-7(11)9(6)14-8/h2-5H,11H2,1H3
616238-78-9Relevant articles and documents
ACTIVATORS OF THE RETINOIC ACID INDUCIBLE GENE "RIG-I' PATHWAY AND METHODS OF USE THEREOF
-
, (2020/03/05)
The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.
Discovery and optimization of p38 inhibitors via computer-assisted drug design
Goldberg, Daniel R.,Hao, Ming-Hong,Qian, Kevin C.,Swinamer, Alan D.,Gao, Donghong A.,Xiong, Zhaoming,Sarko, Chris,Berry, Angela,Lord, John,Magolda, Ronald L.,Fadra, Tazmeen,Kroe, Rachel R.,Kukulka, Alison,Madwed, Jeffrey B.,Martin, Leslie,Pargellis, Christopher,Skow, Donna,Song, Jinhua J.,Tan, Zhulin,Torcellini, Carol A.,Zimmitti, Clare S.,Yee, Nathan K.,Moss, Neil
, p. 4016 - 4026 (2008/02/12)
Integration of computational methods, X-ray crystallography, and structure-activity relationships will be disclosed, which lead to a new class of p38 inhibitors that bind to p38 MAP kinase in a Phe out conformation.
